Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATMJuan Guinea Viniegra, Ricardo Sánchez‐Prieto|Journal of Biological Chemistry|2004Cited by 272
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistanceJesús García‐Cano, Ricardo Sánchez‐Prieto|Oncotarget|2015Cited by 49
ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML TherapyClara Aceves-Luquero, Ricardo Sánchez‐Prieto|PLoS ONE|2009Cited by 47
ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal CarcinomaLaura Arias‐González, Ricardo Sánchez‐Prieto|Neoplasia|2013Cited by 40
Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLCEva María Galán‐Moya, Ricardo Sánchez‐Prieto|PLoS ONE|2011Cited by 40